1 H-indazole Dihydro-chloride 3 . 5 Hydrate ( DY-9760 e ) Is Neuroprotective in Rat Microsphere Embolism : Role of the Cross-Talk between Calpain and Caspase-3 through Calpastatin
F. Han,Y. Shirasaki,K. Fukunaga
2006-01-01
Abstract:Microsphere embolism (ME)-induced cerebral ischemia can elicit various pathological events leading to neuronal death. Western blotting and immunohistochemical studies revealed that expression of calpastatin, an endogenous calpain inhibitor, decreased after ME induction. Calpain activation after ME was apparently due to, in part, a decrease in calpastatin in a late phase of neuronal injury. The time course of that decrease also paralleled caspase-3 activation. In vitro studies demonstrated that calpastatin was degraded by caspase-3 in a Ca /calmodulin (CaM)-dependent manner. Because CaM binds directly to calpastatin, we asked whether a novel CaM antagonist, 3-[2[4-(3-chloro-2-methylphenylmethyl)-1-piperazinyl]ethyl]-5,6dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydro-chloride 3.5 hydrate (DY-9760e), inhibits caspase-3-induced calpastatin degradation during ME-induced neuronal damage. We also tested the effect of DY-9760e on degradation of fodrin, a calpain substrate. Consistent with our hypothesis, DY-9760e (25 or 50 mg/kg i.p.) treatment inhibited degradation of calpastatin and fodrin in a dose-dependent manner. Because DY-9760e showed powerful neuroprotective activity with concomitant inhibition of calpastatin degradation, cross-talk between calpain and caspase-3 through calpastatin possibly accounts for ME-induced neuronal injury. Taken together, both inhibition of caspase-3-induced calpastatin degradation and calpain-induced fodrin breakdown by DY-9760e in part mediate its neuroprotective action. Microspheres infused into the internal carotid artery induce small widespread embolisms, thereby leading to multiple infarct areas in the brain. The pathogenesis of microsphere embolism (ME)-induced brain damage resembles clinical features of human territorial stroke or brain vascular dementia (Demura et al., 1993). ME-induced ischemic injury includes many pathological events, such as release of excitatory amino acids and deprivation of oxygen/glucose (Smith et al., 1990; Takeo et al., 1992). These events then trigger calcium influx into neurons, thereby leading to activation of Ca -dependent signaling, such as Ca /CaM-dependent enzymes and Ca -dependent protease calpains (Hayashi et al., 1998; Takagi et al., 2001). Brain ischemia/reperfusion injury is associated with calpain-induced proteolysis of the cytoskeleton, including fodrin/spectrin (Fokuda et al., 1998; Sato et al., 1999; Yakota et al., 2003). We also documented nitric oxide production through activation of Ca /CaM-dependent nitric-oxide synthase (NOS) in ME-induced ischemia, thereby producing protein tyrosine nitration (Shirakura et al., 2005). The novel CaM inhibitor DY-9760e rescues neurons from ME-induced neuronal damage with concomitant inhibition of both NO production and protein tyrosine nitration (Hashiguchi et al., 2003). Interestingly, the neuroprotective effect of DY-9760e is also highly correlated with inhibition of calpain-induced breakdown of fodrin, a cytoskeletal Article, publication date, and citation information can be found at http://jpet.aspetjournals.org. doi:10.1124/jpet.105.095018. ABBREVIATIONS: ME, microsphere embolism; NOS, nitric-oxide synthase; DY-9760e, 3-[2-[4-(3-chloro-2-methylphenylmethyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydro-chloride 3.5 hydrate; CaM, calmodulin; DMSO, dimethyl sulfoxide; DTT, dithiothreitol; PAGE, polyacrylamide gel electrophoresis; PBS, phosphate-buffered saline; AMC, 7-amino-4-methylcoumarin; FBDP, fodrin breakdown product; MDL28,170, carbobenzoxy-valinyl-phenylalaninal. 0022-3565/06/3172-529–536$20.00 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 317, No. 2 Copyright © 2006 by The American Society for Pharmacology and Experimental Therapeutics 95018/3107514 JPET 317:529–536, 2006 Printed in U.S.A. 529 at A PE T Jornals on A ril 6, 2017 jpet.asjournals.org D ow nladed from and CaM-binding protein (Sato et al., 1999). Therefore, we hypothesize that inhibition of fodrin breakdown by calpain is partly involved in the neuroprotective action of DY-9760e. In addition to calpain activation, caspase-3 plays pivotal roles in apoptotic cell death by inducing Bid and poly(ADPribose) polymerase activation (Affar et al., 2001; Degli Esposti et al., 2003). Inappropriate imbalances between calpain and calpastatin activation may play critical roles in the delayed neuronal death including apoptosis (Rami et al., 2003). Inhibition of nitric oxide production and fodrin breakdown by DY-9760e may suppress apoptotic signals such as caspase-3 activation through maintaining membrane integrity and suppressing mitochondrial damage. Indeed, cross-talk between calpain and caspase-3 has been documented in brain ischemia. For example, calpain-mediated N-terminal truncation of caspase-3 to a p30 polypeptide enhanced caspase-3 activation in one study (Blomgren et al., 2001) and inhibited its activation in another (McGinnis et al., 1999). Calpainmediated N-terminal truncation of caspase-9 results in the loss of ability to activate caspase-3 (Chua et al., 2000; Lankiewicz et al., 2000). Calpastatin, an endogenous calpain inhibitor, is cleaved by caspase-3, thereby leading to loss of its inhibitory effect on calpain (Rami et al., 2003). Calpastatin also inhibits translocation of calpain to the plasma membrane, thereby inhibiting its proteolytic activity toward membranous cytoskeletal proteins such as fodrin (Melloni et al., 1996; Kosower et al., 2000). In addition, calpastatin is a CaM-binding protein; therefore, it leads to the hypothesis that DY-9760e may affect proteolysis of calpastatin, which is mediated by caspase-3. Little is known about the cross-talk between calpain and caspase-3 in brain ischemia-induced neuronal death in vivo. Therefore, we asked whether cross-talk of calpain/caspase-3 participates in ME-induced neuronal damage through calpastatin. We also determined that DY-9760e has an inhibitory effect on calpastatin degradation during ischemia and showed that inhibition of cross-talk between calpain and caspase-3 by DY-9760e probably underlies its neuroprotective action in brain ischemia. Therefore, we propose a novel neuroprotective mechanism of DY-9760e. Materials and Methods A Microsphere-Induced Permanent Focal Cerebral Ischemic Model. All experimental procedures using animals were approved by the Committee on Animal Experiments at Tohoku University. Male Wistar rats weighing 220 to 270 g were subjected to general anesthesia induced by 4% halothane in oxygen, which was maintained by spontaneous breathing of 1.5% halothane in oxygen via a face mask. After placing animals in a supine position, a lateral longitudinal midline neck incision was performed to identify and dissect the left common carotid artery and separate the internal carotid artery from the external one at the bifurcation as the base point. Both external carotid and pterygopalatine arteries were temporarily occluded by aneurysm clips. One thousand nonradioactive microspheres (48.4 0.7 m in diameter) suspended in a 20% dextran solution were injected with a 26 G needle into the left common carotid artery while visualizing flow into the internal carotid artery. The skin was closed, and halothane anesthesia was terminated. Rectal temperature was monitored and maintained at 37 0.5°C with a heating blanket throughout the surgery. Shamoperated groups received the same treatment without microsphere injection. Behavioral changes such as lack of movement, truncal curvature, and forced circling during locomotion after microsphere injection were observed as described previously (Miyake et al., 1993). Neurologic scores were determined 0.5, 24, 48, and 72 h after microsphere injection. Scoring was as follows: grade 0, no deficit; grade 1, right side forelimb weakness and torso turning to the left side when held by tail; grade 2, circling to left side; grade 3, circling to left side and inability to bear weight on the right side; and grade 4, no spontaneous locomotor activity. Rats with grade 0 and grade 4 were not used for subsequent experiments. Rats were decapitated at 2, 6, 12, 24, 48, and 72 h after injection of microspheres, and the striatum and cortical regions of the ipsilateral hemisphere were dissected for immunoblotting analyses. Drug Treatments. DY-9760e was dissolved with 100% DMSO and diluted in a 5% glucose solution to a final concentration of 1% DMSO. The microsphere-induced cerebral ischemic model was prepared as described above. After microsphere injection, rats were treated with DY-9760e at 12.5 or 25 mg/kg intraperitoneally. In each case, DY-9760e was injected twice 30 min and 6 h after microsphere injection. Vehicle-treated animals were administered the same volume of 1% DMSO in 5% glucose 30 min and 6 h after microsphere injection, and sham groups received the same experimental procedures without microsphere injection. The dose of DY-9760e used did not affect the mean of arterial blood pressure monitored 30 min after DY-9760e administration (data not shown). Western Blotting Analysis. After decapitation, brains were removed and rinsed once with ice-cold 0.32 M sucrose. Coronal sections of 2 mm were prepared by a hand brain slicer, and ipsilateral and contralateral hemispheres including cortex and striatum were dissected and stored at 80°C. Frozen brain tissues were homogenized in buffer containing 50 mM Tris-HCl, pH 7.4, 0.5% Triton X-100, 4 mM EGTA, 10 mM EDTA, 1 mM Na3VO4, 30 mM sodium pyrophosphate, 50 mM NaF, 100 nM calyculin A, 50 g/ml leupeptin, 25 g/ml pepstatin A, 50 g/ml trypsin inhibitor, and 1 mM dithiothreitol (DTT). Insoluble material was removed by a 20-min centrifugation at 15,000g. After determining protein concentration in each fraction using Bradford’s solution, samples containing equivalent amounts of protein were applied to 10 to 15% acrylamide-denaturing gel (SDSPAGE) (Laemmli, 1970). Proteins were then transferred to an Immobilon polyvinylidene difluoride transfer me